<?xml version="1.0" encoding="UTF-8"?>
<iati-activities version="2.03">
 <iati-activity default-currency="USD" hierarchy="2" iati-activities:version="2.03" xml:lang="EN" xmlns:gavi="http://gavi.org/" xmlns:iati-activities="http://d-portal.org/xmlns/iati-activities">
  <iati-identifier>47122-YEM-TD</iati-identifier>
  <reporting-org ref="47122" type="40">
   <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
  </reporting-org>
  <title>
   <narrative xml:lang="EN">Yemen: Tetanus and Diphtheria</narrative>
   <narrative xml:lang="FR">Y&#xE9;men (le): T&#xE9;tanos et dipht&#xE9;rie</narrative>
  </title>
  <description type="1">
   <narrative xml:lang="FR">Garantir la fiabilit&#xE9; et la p&#xE9;rennit&#xE9; des approvisionnements en vaccins pentavalent &#xE0; des prix abordables. Une Vaccination systematique et une une aide au financement des vaccins antidipht&#xE9;rique-antit&#xE9;tanique-anticoquelucheux (DTC), anti-h&#xE9;patite B et anti-Haemophilius influenzae type b (Hib) depuis sa cr&#xE9;ation. Cependant, pour rem&#xE9;dier &#xE0; la faible demande historique du vaccin anti-Hib dans nombre de pays, Gavi a &#xE9;galement commenc&#xE9; &#xE0; offrir le vaccin pentavalent en 2001. L&#x2019;objectif &#xE9;tait d&#x2019;&#xE9;largir la couverture par l&#x2019;ajout des vaccins anti-Hib et anti-h&#xE9;patite B dans le cadre de la vaccination syst&#xE9;matique. En 2012, Gavi a d&#xE9;cid&#xE9; de n&#x2019;attribuer une aide au financement des vaccins anti-h&#xE9;patite B et anti-Hib que si ceux-ci &#xE9;taient administr&#xE9;s au moyen du vaccin pentavalent cinq-en-un.
Le pentavalent contient cinq vaccins diff&#xE9;rents dans une fiole et prot&#xE8;ge donc de cinq maladies : dipht&#xE9;rie, coqueluche, t&#xE9;tanos (DTC), h&#xE9;patite B et Haemophilus influenzae type B (Hib).

Successeur du vaccin DTC, il a &#xE9;t&#xE9; introduit pour accro&#xEE;tre la couverture des vaccins anti-h&#xE9;patite B et anti-Hib en les ajoutant au programme de vaccination syst&#xE9;matique.</narrative>
   <narrative xml:lang="EN">Gavi proivdes support to Tetanus vaccine. Available as monovalent tetanus toxoid (TT), in bivalent combination with diphtheria toxoid (DT) or low-dose diphtheria toxoid (Td), or as trivalent vaccine that also includes whole-cell (wP) or acellular (aP) pertussis vaccine.</narrative>
  </description>
  <description type="4">
   <narrative xml:lang="FR">Cette activit&#xE9; d&#xE9;taille notre travail sur le T&#xE9;tanos et dipht&#xE9;rie en Y&#xE9;men (le), gr&#xE2;ce &#xE0; la mise &#xE0; disposition des donn&#xE9;es budg&#xE9;taires et des transactions. Nous fournissons &#xE9;galement les documents pertinents qui guident ces activit&#xE9;s que sont les formulaires de demande de soutien fournis par le gouvernement de Y&#xE9;men (le) ainsi que les lettres de d&#xE9;cisions &#xE9;mises par Gavi, pour progresser. Ces documents d&#xE9;crivent les activit&#xE9;s, les objectifs ainsi que les b&#xE9;n&#xE9;ficiaires.</narrative>
   <narrative xml:lang="EN">This activity details our work on Tetanus and Diphtheria in Yemen through the provision of budget and transaction data.  We also provide the relevant documents that guide these activities, which are the support request proposal(s) provided by the Government of Yemen, as well as the decision letter(s) issued by Gavi, for progress.  These documents describe the activities, the objectives as well as the beneficiaries.</narrative>
  </description>
  <participating-org ref="47122" role="1" type="40">
   <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
  </participating-org>
  <participating-org ref="47122" role="3" type="40">
   <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
  </participating-org>
  <participating-org role="4" type="10">
   <narrative xml:lang="EN">The Government of Yemen</narrative>
  </participating-org>
  <participating-org ref="XM-DAC-41122" role="4" type="40">
   <narrative xml:lang="EN">UNICEF Supply Division</narrative>
  </participating-org>
  <other-identifier ref="47122" type="B1">
   <owner-org ref="47122">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </owner-org>
  </other-identifier>
  <other-identifier ref="47122-18-YEM-39A-A" type="A3"></other-identifier>
  <activity-status code="2"></activity-status>
  <activity-date iso-date="2018-01-01" type="1"></activity-date>
  <activity-date iso-date="2018-01-01" type="2"></activity-date>
  <activity-date iso-date="2021-12-31" type="3"></activity-date>
  <contact-info type="1">
   <organisation>
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </organisation>
   <email>info@gavi.org</email>
   <website>http://www.gavi.org/</website>
  </contact-info>
  <activity-scope code="4"></activity-scope>
  <recipient-country code="YE" percentage="100"></recipient-country>
  <location>
   <location-reach code="1"></location-reach>
   <location-id code="YE" vocabulary="A4"></location-id>
   <name>
    <narrative xml:lang="EN">Sanaa</narrative>
   </name>
   <administrative code="YE" vocabulary="A4"></administrative>
   <point srsName="http://www.opengis.net/def/crs/EPSG/0/4326">
    <pos>15.35472 44.20667</pos>
   </point>
   <exactness code="2"></exactness>
   <location-class code="2"></location-class>
  </location>
  <sector code="TD" percentage="100" vocabulary="99">
   <narrative xml:lang="EN">Tetanus and Diphtheria</narrative>
  </sector>
  <sector code="12250" percentage="100" vocabulary="1"></sector>
  <tag code="1" vocabulary="2"></tag>
  <tag code="10" vocabulary="2"></tag>
  <tag code="11" vocabulary="2"></tag>
  <tag code="13" vocabulary="2"></tag>
  <tag code="16" vocabulary="2"></tag>
  <tag code="17" vocabulary="2"></tag>
  <tag code="2" vocabulary="2"></tag>
  <tag code="3" vocabulary="2"></tag>
  <tag code="4" vocabulary="2"></tag>
  <tag code="5" vocabulary="2"></tag>
  <tag code="7" vocabulary="2"></tag>
  <tag code="8" vocabulary="2"></tag>
  <tag code="9" vocabulary="2"></tag>
  <policy-marker code="1" significance="2" vocabulary="1"></policy-marker>
  <policy-marker code="9" significance="2" vocabulary="1"></policy-marker>
  <collaboration-type code="2"></collaboration-type>
  <default-flow-type code="10"></default-flow-type>
  <default-finance-type code="110"></default-finance-type>
  <default-aid-type code="C01" vocabulary="1"></default-aid-type>
  <default-tied-status code="5"></default-tied-status>
  <budget status="2" type="2">
   <period-start iso-date="2018-01-01"></period-start>
   <period-end iso-date="2018-12-31"></period-end>
   <value currency="USD" value-date="2022-06-09">700690.33</value>
  </budget>
  <capital-spend percentage="0"></capital-spend>
  <transaction ref="YEMTD2018">
   <transaction-type code="2"></transaction-type>
   <transaction-date iso-date="2018-01-01"></transaction-date>
   <value currency="USD" value-date="2018-01-01">700690.33</value>
   <description>
    <narrative xml:lang="EN">Approved 2018 budget for Yemen TD</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org type="10">
    <narrative xml:lang="EN">The Government of Yemen</narrative>
   </receiver-org>
  </transaction>
  <transaction>
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2018-04-04"></transaction-date>
   <value currency="USD" value-date="2018-04-04">801300</value>
   <description>
    <narrative xml:lang="EN">Vaccine disbursement for programme YEM-TD-CAM-CU-FER-VAC</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org ref="XM-DAC-41122" type="40">
    <narrative xml:lang="EN">UNICEF Supply Division</narrative>
   </receiver-org>
  </transaction>
  <transaction>
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2018-10-01"></transaction-date>
   <value currency="USD" value-date="2018-10-01">466000</value>
   <description>
    <narrative xml:lang="EN">Vaccine disbursement for programme YEM-TD-CAM-CU-FER-VAC</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org ref="XM-DAC-41122" type="40">
    <narrative xml:lang="EN">UNICEF Supply Division</narrative>
   </receiver-org>
  </transaction>
  <transaction>
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2019-05-30"></transaction-date>
   <value currency="USD" value-date="2019-05-30">-466000</value>
   <description>
    <narrative xml:lang="EN">Vaccine disbursement for programme YEM-TD-CAM-CU-FER-VAC</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org ref="XM-DAC-41122" type="40">
    <narrative xml:lang="EN">UNICEF Supply Division</narrative>
   </receiver-org>
  </transaction>
  <transaction ref="1700000152">
   <transaction-type code="3"></transaction-type>
   <transaction-date iso-date="2021-07-15"></transaction-date>
   <value currency="USD" value-date="2021-07-15">-100602.47</value>
   <description>
    <narrative xml:lang="EN">Vaccine disbursement for programme YEM-TD-CAM-CU-FER-VAC</narrative>
   </description>
   <provider-org ref="47122" type="40">
    <narrative xml:lang="EN">Gavi, The Vaccine Alliance</narrative>
   </provider-org>
   <receiver-org ref="XM-DAC-41122" type="40">
    <narrative xml:lang="EN">UNICEF Supply Division</narrative>
   </receiver-org>
  </transaction>
  <related-activity ref="47122-YEM" type="1"></related-activity>
  <conditions attached="1">
   <condition type="3">
    <narrative xml:lang="EN">Conditions are available in the decision letters</narrative>
   </condition>
  </conditions>
 </iati-activity>
</iati-activities>
